BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 16253892)

  • 1. Endocrine tumours of the stomach.
    Delle Fave G; Capurso G; Milione M; Panzuto F
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
    Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
    Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gastric carcinoid--pathogenesis and treatment].
    Bründler R; Gebbers JO; Criblez D
    Schweiz Med Wochenschr; 1999 Jun; 129(25):945-50. PubMed ID: 10422189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication?
    Clemente G; Sarno G; Giordano M; De Rose AM; Giovannini I; Vecchio FM; Nuzzo G
    Minerva Chir; 2007 Oct; 62(5):421-4. PubMed ID: 17947953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinoids in patients with hypergastrinemia.
    Jordan PH; Barroso A; Sweeney J
    J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: Pathogenesis and management of gastric carcinoid tumours.
    Burkitt MD; Pritchard DM
    Aliment Pharmacol Ther; 2006 Nov; 24(9):1305-20. PubMed ID: 17059512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan.
    Sato Y; Imamura H; Kaizaki Y; Koizumi W; Ishido K; Kurahara K; Suzuki H; Fujisaki J; Hirakawa K; Hosokawa O; Ito M; Kaminishi M; Furuta T; Chiba T; Haruma K
    Dig Endosc; 2014 May; 26(3):377-84. PubMed ID: 24188531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.
    Hoshino M; Omura N; Yano F; Tsuboi K; Matsumoto A; Yamamoto SR; Akimoto S; Kashiwagi H; Yanaga K
    Hepatogastroenterology; 2010; 57(98):379-82. PubMed ID: 20583448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
    Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology and management of gastric carcinoid tumours: a review.
    Modlin IM; Kidd M; Lye KD
    Eur J Surg; 2002; 168(12):669-83. PubMed ID: 15362575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ghrelin immunoreactive cells in gastric endocrine tumors and their relation to plasma ghrelin concentration.
    Tsolakis AV; Stridsberg M; Grimelius L; Portela-Gomes GM; Falkmer SE; Waldum HL; Janson ET
    J Clin Gastroenterol; 2008 Apr; 42(4):381-8. PubMed ID: 18277901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
    Solcia E; Rindi G; Larosa S; Capella C
    Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger-Ellison syndrome can be symptomatic, demonstrate aggressive growth, and require surgical treatment.
    Norton JA; Melcher ML; Gibril F; Jensen RT
    Surgery; 2004 Dec; 136(6):1267-74. PubMed ID: 15657586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes.
    Bordi C; Corleto VD; Azzoni C; Pizzi S; Ferraro G; Gibril F; Delle Fave G; Jensen RT
    J Clin Endocrinol Metab; 2001 May; 86(5):2236-42. PubMed ID: 11344233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple gastric carcinoids and endocrine cell micronests in type A gastritis: Nuclear morphometric and immunohistochemical analysis.
    Iwai K; Yao T; Nakamura S; Matsumoto T; Nishiyama K; Iida M; Tsuneyoshi M
    Oncol Rep; 2005 Mar; 13(3):397-404. PubMed ID: 15706407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
    Feurle GE
    Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy.
    Hopper AD; Bourke MJ; Hourigan LF; Tran K; Moss A; Swan MP
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1516-21. PubMed ID: 19743997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.